We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Integrated Solution for Diabetes Testing Is Efficient

By HospiMedica staff writers
Posted on 28 Aug 2007
Clinical laboratories will be provided with an integrated system for diabetes testing that automates sample processing, eliminates sample splitting, and improves operating efficiency while reducing costs and errors.

Sysmex America, Inc. (Mundelein, IL, USA) and Bio-Rad Laboratories, Inc. (Hercules, CA, USA) have entered into a non-exclusive, multi-year distribution agreement to jointly market their complementary products with the aim of improving the efficiency and quality of diabetes testing. Sysmex will add Bio-Rad's diabetes testing method to the Sysmex HST-N automation line. Bio-Rad will supply their Variant II turbo link. Sysmex and Bio-Rad will work together to provide seamless service, training, installation, and customer support services.

Bio-Rad's hemoglobin A1c (A1C) blood test measures the amount of glucose attached to the hemoglobin in the red blood cell. This provides an estimate of how well blood glucose levels have been controlled during the previous three to four months. Bio-Rad's test is the industry's gold standard technology for determining whether a patient's diabetes is under control.

We are delighted to continue our long-standing history with Bio-Rad Laboratories, said John Kershaw, president, Sysmex America. The Bio-Rad Variant II turbo link is a perfect complement to the Sysmex HST-N hematology automation line. With the addition of A1c to our automation line, we can truly manage all the testing of the lavender top hematology sample tubes in the laboratory. Sysmex's lavender top management system provides hematology laboratories with the ability to conduct analysis of 90% of tests compatible with EDTA samples, such as complete blood count (CBC), Clostridium difficile, erythrocyte sedimentation rate (ESR), and A1c.

We are pleased to work with Sysmex in offering this integrated testing solution to clinical laboratories as it will enable them to provide superior diabetes testing services to doctors and their patients throughout the United States, said John Goetz, Bio-Rad vice president and group manager of clinical diagnostics.


Related Links:
Sysmex America
Bio-Rad Laboratories

New
Gold Member
Syphilis Screening Test
VDRL Antigen MR
Automated Blood Typing System
IH-500 NEXT
New
Gold Member
Rotavirus Rapid Test
Rotavirus Cassette
New
Toxoplasma Gondii Test
Toxo IgG ELISA Kit

Latest Industry News

Bio-Techne and ALZpath Partner to Advance Neurodegenerative Disease Research and Treatment

Microbiologics Acquires Diagnostic Quality Controls Manufacturer SensID

Beckman Coulter Partners with BioPorto for Global Distribution of Acute Kidney Injury NGAL Tests